ArticleCureus2024
Coronavirus Disease 2019 (COVID-19)-Induced Hyponatremia: A Challenging Geriatric Case.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Coronavirus disease 2019 (COVID-19) has presented numerous challenges to the medical community, including atypical complications such as electrolyte imbalances and organ dysfunction. This case report describes a 91-year-old female with a history of chronic medical conditions, including chronic kidney disease (CKD) stage 3, who presented with hypoxemic respiratory failure, transaminitis, and persistent hyponatremia during the course of her COVID-19 infection. Despite initial suspicion of the syndrome of inappropriate antidiuretic hormone secretion (SIADH), caused by elevated antidiuretic hormone (ADH), the patient's normal osmolality and sodium excretion suggested other contributing factors, such as poor oral intake (per os, PO), volume depletion, and pseudo-acute kidney injury (pseudo-AKI) leading to hypovolemic hyponatremia. Her transaminitis resolved with supportive care, allowing for the safe initiation of remdesivir. The patient's gradual correction of hyponatremia without complications highlights the importance of individualized management. This case highlights the varied and systemic effects of COVID-19, emphasizing the need for comprehensive care and monitoring of electrolyte disturbances during hospitalization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.